Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
TSE:4502
Price:
4 125 JPY
-0.43%
Updated:
May 6, 2024
Balance Sheet
Balance Sheet Decomposition
Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
| Current Assets | 2.4T |
| Cash & Short-Term Investments | 317.4B |
| Receivables | 743.1B |
| Other Current Assets | 1.4T |
| Non-Current Assets | 11.8T |
| Long-Term Investments | 372.9B |
| PP&E | 1.8T |
| Intangibles | 9.2T |
| Other Non-Current Assets | 371.4B |
| Current Liabilities | 2.3T |
| Accounts Payable | 483.7B |
| Other Current Liabilities | 1.8T |
| Non-Current Liabilities | 5.2T |
| Long-Term Debt | 4.3T |
| Other Non-Current Liabilities | 905B |
Balance Sheet
Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
Currency: JPY
| Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
353 178
|
461 007
|
437 916
|
278 488
|
243 324
|
462 890
|
188 640
|
335 027
|
389 058
|
229 557
|
|
| Cash Equivalents |
353 178
|
461 007
|
437 916
|
278 488
|
243 324
|
462 890
|
188 640
|
335 027
|
389 058
|
229 557
|
|
| Short-Term Investments |
497 851
|
252 416
|
122 110
|
97 650
|
131 862
|
262 929
|
464 796
|
667 793
|
485 942
|
324 147
|
|
| Total Receivables |
442 664
|
466 829
|
430 571
|
444 778
|
428 792
|
749 119
|
784 921
|
812 714
|
724 377
|
681 693
|
|
| Accounts Receivables |
375 940
|
400 846
|
376 490
|
356 453
|
360 833
|
657 681
|
670 708
|
707 487
|
617 517
|
575 430
|
|
| Other Receivables |
66 724
|
65 983
|
54 081
|
88 325
|
67 959
|
91 438
|
114 213
|
105 227
|
106 860
|
106 263
|
|
| Inventory |
254 329
|
262 354
|
254 010
|
226 048
|
212 944
|
919 670
|
759 599
|
753 881
|
853 167
|
986 457
|
|
| Other Current Assets |
44 514
|
77 466
|
129 180
|
213 452
|
61 886
|
598 429
|
271 476
|
143 478
|
141 098
|
176 102
|
|
| Total Current Assets |
1 592 536
|
1 520 072
|
1 373 787
|
1 260 416
|
1 078 808
|
2 993 037
|
2 469 432
|
2 712 893
|
2 593 642
|
2 397 956
|
|
| PP&E Net |
542 253
|
526 162
|
551 916
|
527 344
|
536 801
|
1 331 931
|
1 386 370
|
1 453 917
|
1 582 800
|
1 691 229
|
|
| PP&E Gross |
542 253
|
526 162
|
551 916
|
527 344
|
536 801
|
1 331 931
|
1 386 370
|
1 453 917
|
1 582 800
|
1 691 229
|
|
| Accumulated Depreciation |
625 430
|
625 430
|
671 923
|
607 089
|
654 597
|
639 591
|
697 754
|
737 818
|
870 208
|
1 007 754
|
|
| Intangible Assets |
1 135 597
|
939 381
|
743 128
|
1 063 037
|
1 014 264
|
4 751 169
|
4 171 361
|
3 909 106
|
3 818 544
|
4 269 657
|
|
| Goodwill |
814 671
|
821 911
|
779 316
|
1 019 574
|
1 029 248
|
4 240 251
|
4 012 528
|
4 033 917
|
4 407 749
|
4 790 723
|
|
| Long-Term Investments |
234 890
|
281 966
|
186 190
|
303 047
|
304 385
|
299 922
|
369 455
|
348 350
|
330 133
|
378 857
|
|
| Other Long-Term Assets |
249 197
|
206 700
|
189 748
|
173 376
|
142 957
|
176 463
|
411 948
|
454 110
|
445 150
|
429 328
|
|
| Other Assets |
814 671
|
821 911
|
779 316
|
1 019 574
|
1 029 248
|
4 240 251
|
4 012 528
|
4 033 917
|
4 407 749
|
4 790 723
|
|
| Total Assets |
4 569 144
N/A
|
4 296 192
-6%
|
3 824 085
-11%
|
4 346 794
+14%
|
4 106 463
-6%
|
13 792 773
+236%
|
12 821 094
-7%
|
12 912 293
+1%
|
13 178 018
+2%
|
13 957 750
+6%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
129 345
|
124 365
|
135 205
|
125 713
|
133 705
|
212 348
|
211 627
|
232 105
|
295 933
|
307 453
|
|
| Short-Term Debt |
1 226
|
0
|
0
|
405 054
|
18
|
500 002
|
5 014
|
69
|
285
|
256
|
|
| Current Portion of Long-Term Debt |
154 178
|
154 178
|
228 464
|
139 974
|
0
|
484 944
|
581 803
|
22 084
|
203 708
|
339 344
|
|
| Other Current Liabilities |
518 005
|
792 494
|
493 544
|
695 605
|
603 786
|
1 355 755
|
1 377 454
|
1 518 918
|
1 645 804
|
1 834 887
|
|
| Total Current Liabilities |
802 754
|
1 016 824
|
857 213
|
1 366 346
|
737 509
|
2 553 049
|
2 175 898
|
1 773 176
|
2 145 730
|
2 481 940
|
|
| Long-Term Debt |
704 581
|
629 416
|
539 760
|
599 862
|
985 644
|
4 766 005
|
4 506 487
|
4 613 218
|
4 141 418
|
4 042 741
|
|
| Deferred Income Tax |
280 595
|
156 132
|
123 469
|
153 396
|
90 725
|
783 356
|
765 079
|
576 542
|
473 145
|
295 178
|
|
| Minority Interest |
69 896
|
69 129
|
62 511
|
54 704
|
19 985
|
4 006
|
4 003
|
4 140
|
504
|
549
|
|
| Other Liabilities |
240 579
|
287 644
|
292 440
|
278 225
|
275 176
|
504 372
|
646 144
|
772 180
|
734 202
|
783 219
|
|
| Total Liabilities |
2 098 405
N/A
|
2 159 145
+3%
|
1 875 393
-13%
|
2 452 533
+31%
|
2 109 039
-14%
|
8 610 788
+308%
|
8 097 611
-6%
|
7 739 256
-4%
|
7 494 999
-3%
|
7 603 627
+1%
|
|
| Equity | |||||||||||
| Common Stock |
63 562
|
64 044
|
64 766
|
65 203
|
77 914
|
1 643 585
|
1 668 123
|
1 668 145
|
1 676 263
|
1 676 345
|
|
| Retained Earnings |
1 901 307
|
1 601 326
|
1 523 127
|
1 511 817
|
1 557 307
|
1 595 431
|
1 369 972
|
1 509 906
|
1 479 716
|
1 541 146
|
|
| Additional Paid In Capital |
39 866
|
59 575
|
68 829
|
74 972
|
90 740
|
1 650 232
|
1 680 287
|
1 688 424
|
1 708 873
|
1 728 830
|
|
| Unrealized Security Profit/Loss |
60 771
|
60 771
|
0
|
67 980
|
73 037
|
46 380
|
22 891
|
41 983
|
22 068
|
12 470
|
|
| Treasury Stock |
621
|
18 203
|
0
|
48 734
|
74 373
|
57 142
|
87 463
|
59 552
|
116 007
|
100 317
|
|
| Other Equity |
405 854
|
354 620
|
269 421
|
223 023
|
272 799
|
303 499
|
69 673
|
324 131
|
912 106
|
1 495 649
|
|
| Total Equity |
2 470 739
N/A
|
2 137 047
-14%
|
1 948 692
-9%
|
1 894 261
-3%
|
1 997 424
+5%
|
5 181 985
+159%
|
4 723 483
-9%
|
5 173 037
+10%
|
5 683 019
+10%
|
6 354 123
+12%
|
|
| Total Liabilities & Equity |
4 569 144
N/A
|
4 296 192
-6%
|
3 824 085
-11%
|
4 346 794
+14%
|
4 106 463
-6%
|
13 792 773
+236%
|
12 821 094
-7%
|
12 912 293
+1%
|
13 178 018
+2%
|
13 957 750
+6%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
789
|
786
|
784
|
781
|
781
|
1 555
|
1 558
|
1 563
|
1 550
|
1 555
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
